Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

NKTR

Nektar Therapeutics

May 12 • 03:24PM ET

77.53

-1.19 -1.52 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: JANX ARVN XNCR IOVA ALLO

| Held by: VTI VXF SCHA XPH IHE VHT PRFZ LFSC DWAS ITOT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-8.42	Insider Own	2.15%	Shs Outstand	33.21M	Perf Week	-7.88%
Market Cap	2.62B	Forward P/E	-	EPS next Y	-11.12	Insider Trans	-1.17%	Shs Float	32.50M	Perf Month	-3.64%
Enterprise Value	2.19B	PEG	-	EPS next Q	-2.04	Inst Own	66.37%	Short Float	12.62%	Perf Quarter	38.44%
Income	-158.10M	P/S	47.08	EPS this Y	6.69%	Inst Trans	24.55%	Short Ratio	3.66	Perf Half Y	38.51%
Sales	55.63M	P/B	2.74	EPS next Y	-22.43%	ROA	-31.01%	Short Interest	4.10M	Perf YTD	83.36%
Book/sh	28.28	P/C	4.61	EPS next 5Y	-5.49%	ROE	-53.60%	52W High	109.00 -28.88%	Perf Year	623.05%
Cash/sh	16.83	P/FCF	-	EPS past 3/5Y	30.93% 23.59%	ROIC	-22.68%	52W Low	7.99 870.28%	Perf 3Y	609.25%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-15.66% -18.43%	Gross Margin	98.65%	Volatility	4.69% 5.79%	Perf 5Y	-72.17%
Dividend TTM	-	EV/Sales	39.44	EPS Y/Y TTM	11.52%	Oper. Margin	-224.08%	ATR (14)	4.79	Perf 10Y	-60.52%
Dividend Ex-Date	-	Quick Ratio	10.21	Sales Y/Y TTM	-36.24%	Profit Margin	-284.18%	RSI (14)	41.77	Recom	1.20
Dividend Gr. 3/5Y	- -	Current Ratio	10.21	EPS Q/Q	49.83%	SMA20	-10.36%	Beta	-0.79	Target Price	153.25
Payout	-	Debt/Eq	0.25	Sales Q/Q	3.83%	SMA50	-1.36%	Rel Volume	0.50	Prev Close	78.72
Employees	63	LT Debt/Eq	0.21	Earnings	May 07 AMC	SMA200	38.98%	Avg Volume	1.12M	Price	77.53
IPO	May 03, 1994	Option/Short	Yes / Yes	EPS/Sales Surpr.	-15.02% 1.59%	Trades		Volume	511,312	Change	-1.52%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)